Sanofi cuts research staffers in Boston as reorganization looms: report

Sanofi ($SNY) is cutting more than 30 lab workers in its Boston hub, according to the Boston Globe. Citing staffers, the report notes that the jobs are being axed in groups that were part of the Genzyme organization acquired by Sanofi. The layoffs may presage more cuts as Sanofi is rumored to be readying a company-wide reorganization, which includes cutting hundreds of unfilled job openings in France. Report

Suggested Articles

Outgoing BIO Chair John Maraganore and his successor, Jeremy Levin, reflected on drug pricing, its drivers and its place in the innovation ecosystem.

The study is assessing the effect of the oral AXL inhibitor when given to elderly AML patients in combination with low-intensity chemotherapy.

The proportion of patients who had a greater than 1 g/dL increase in hemoglobin is down on GBT’s prior update but still superior to placebo.